The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 13, 2021

Filed:

Dec. 12, 2017
Applicant:

Codex Dna, Inc., San Diego, CA (US);

Inventors:

John E. Gill, San Marcos, CA (US);

Daniel G. Gibson, Carlsbad, CA (US);

Lixia Fu, San Diego, CA (US);

Assignee:

Codex DNA, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12N 15/10 (2006.01); C12Q 1/686 (2018.01); C07H 19/173 (2006.01); C12N 9/22 (2006.01); C07H 19/073 (2006.01); C12P 19/34 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/686 (2013.01); C07H 19/073 (2013.01); C07H 19/173 (2013.01); C12N 9/22 (2013.01); C12N 15/09 (2013.01); C12N 15/10 (2013.01); C12N 15/1031 (2013.01); C12P 19/34 (2013.01); C12Y 302/02027 (2013.01);
Abstract

The invention provides compositions and methods for assembling a DNA molecule having a desired sequence. The methods involve contacting a DNA polymerase, dNTPs, and a plurality of pairs of oligonucleotides. The oligonucleotides of a pair have a portion of the desired sequence, and an internal sequence that overlaps and is complementary to an internal sequence of the other oligonucleotide of the pair, and, when arranged in order, they have at least a portion of the desired sequence. The oligonucleotides also have a 3' or a 5′ primer binding sequence having a binding site for a primer. The oligonucleotides that correspond to the end oligonucleotides of the desired sequence also have a universal 3′ flanking sequence and a universal 5′ flanking sequence, respectively. The methods involve performing a first amplification reaction on the plurality of pairs of oligonucleotides; removing the 3′ and 5′ primer binding sequences from the plurality of pairs of oligonucleotides; and subjecting the plurality of pairs of oligonucleotides to an assembly reaction to thereby assemble the dsDNA molecule having the desired sequence.


Find Patent Forward Citations

Loading…